Although the calculated binding affinities of curcuminoids and known CFTR-modulating drugs are comparable (Figure 9D), the very poor bioavailability of curcumin would not seem to justify the in vivo pharmacological responses against CF, which are indeed observed (Supplementary Table S1). Here, CFTR is linked to cystic fibrosis.